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In all animal cells, phospholipids are asymmetrically distributed between the outer 
and inner leaflets of the plasma membrane1. This asymmetrical phospholipid 
distribution is disrupted in various biological systems. For example, when blood 
platelets are activated, they expose phosphatidylserine (PS) to trigger the clotting 
system2,3. The PS exposure is believed to be mediated by Ca2+-dependent 
phospholipid scramblases that bidirectionally transport phospholipids1,4, but its 
molecular mechanism has remained elusive. Here we found that when a mouse B-
cell line, Ba/F3, was treated with a Ca2+-ionophore under Ca2+-low conditions, it 
reversibly exposed PS. Using this property, we established a Ba/F3 subline that 
strongly exposed PS by repetitive FACS sorting. A cDNA library was constructed 
from the subline, and a cDNA that caused Ba/F3 to spontaneously expose PS was 
identified by expression cloning. The cDNA encoded a constitutively active mutant 
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of TMEM16F (Transmembrane protein 16F), a protein with eight transmembrane 
segments5. The wild-type TMEM16F was localized on the plasma membrane, and 
conferred the Ca2+-dependent scrambling of phospholipids. A patient with Scott 
Syndrome6,7, which results from a defect in phospholipid scrambling activity8,9, 
was found to carry a mutation at a splice-acceptor site of the TMEM16F gene, 
causing the premature termination of the protein. We conclude that TMEM16F is 
an essential component for the Ca2+-dependent PS exposure on the cell surface.  
When mouse Ba/F3 cells were treated with 1.0 µM A23187 for 15 min in the presence 
of 0.5 mM CaCl2, the cells underwent necrosis or became propidium iodide (PI)-
positive. However, when the same treatment was performed in Ca2+-free condition, 
most of the cells exposed PS, and the PI-positive population was low (Fig. 1a). 
Chelating intracellular Ca2+ with BAPTA-AM blocked the PS exposure (Fig. 1b), 
indicating that the process required mobilization of intracellular calcium. This PS-
exposure was reversible. That is, treating the PS-exposing cells with BAPTA-AM at 
37°C for 5 min (Fig. 1c) or culturing them in Ca2+-free medium at 37°C for 12 h (data 
not shown), eliminated the PS from the cell surface. These results suggested that under 
Ca2+-low conditions, A23187 mobilized the intracellular Ca2+, which activated a 
phospholipid scramblase to expose PS. Upon reduction of the intracellular Ca2+ 
concentration, the phospholipid scramblase lost activity, and flippases returned the PS 
to the inner leaflet.  
To characterize the PS-exposure process, we used its reversible nature under Ca2+-
low conditions to establish a cell line that over-exposed PS. Ba/F3 cells were treated 
with 1.0 µM A23187 in the absence of calcium, and subjected to FACS sorting based on 
PS exposure. A population (0.5-5%) that showed intense Annexin V staining was 
collected, cultured for 15 h in Ca2+-free medium, returned to normal medium, and 
subjected to the next sorting. After this cycle of sorting and expansion was repeated 12 
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times, the cells (Ba/F3-PS12) exhibited about a 100-fold higher staining with Annexin 
V than the original Ba/F3 cells (Ba/F3-PS0) upon treatment with 125 nM of A23187 
(Fig. 1d). The sorting and expansion was repeated another seven times, and the resulting 
cell line (Ba/F3-PS19) was used for further studies.  
There were two possible causes of the strong PS exposure in Ba/F3-PS19. One 
was the over-expression or over-activation of phospholipid scramblase, and the other 
was the inactivation of flippase10 that transports PS from the outer to inner leaflet of the 
plasma membranes. To examine which possibility was correct, DsRed-expressing 
Ba/F3-PS19 was fused with the GFP-labeled parental Ba/F3 (Ba/F3-PS0). The PS-
exposure response of the hybrid cells to 1.0 µM A23187 was similar, or slightly weaker 
than that of Ba/F3-PS19 (Fig. 1e), suggesting that the phenotype of Ba/F3-PS19 was 
dominant to that of Ba/F3-PS0, and that the phospholipid scramblase was over-activated 
in Ba/F3-PS19. To identify the gene responsible for the enhanced phospholipid 
scramblase activity, a cDNA library (9.3 x 105 clones) was prepared from Ba/F3-PS19, 
and introduced into the parental Ba/F3. The stably transformed cells were treated with 
125 nM A23187, and a population that stained strongly with Annexin V was sorted 
(Fig. 1f). At the third cycle of sorting and expansion (Library-Derived (LD)-PS3), about 
35% of the cells exposed PS without A23187 treatment, and this cell population (LD-
PS4) was characterized.   
The LD-PS4 cells carried 2-3 different cDNAs, but the TMEM16F cDNA 
(GenBank NM_175344) was present in two independent experiments, suggesting that 
TMEM16F caused the PS exposure. The two TMEM16F cDNAs identified in the 
different experiments contained an A-to-G mutation at nucleotide 1226, which caused 
an aspartic acid to be replaced by glycine at codon 409 (Fig. 2a). TMEM16A, another 
member of the TMEM16 family, was recently shown to be a Ca2+-dependent Cl- 
channel11-13. However, the Cl- channel activity of TMEM16F was low compared to that 
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of TMEM16A14. To examine the function of TMEM16F, the wild-type and mutant 
(D409G) forms of TMEM16F were tagged with Flag or mRFP at C-terminus, and 
expressed in Ba/F3 or human 293T cells. Western blotting of the cell lysates with anti-
Flag showed broad bands at 125 and 500 kDa on SDS-PAGE (Fig. 2b), suggesting that 
mouse TMEM16F (calculated Mr. 106,000) is glycosylated and/or aggregated. 
Observation of the 293T cells expressing TMEM16F-mRFP indicated that TMEM16F 
is at the plasma membrane (Fig. 2c).  
Annexin V bound to the Ba/F3 expressing the D409G mutant, but not the wild-
type TMEM16F (Fig. 2d), suggesting that the mutant TMEM16F-expressing cells 
constitutively expose PS. This was confirmed by binding of MFG-E8 that specifically 
binds to PS15,16 (Supplementary Fig. 1). Chelating the intracellular Ca2+ by BAPTA-AM 
reduced the exposed PS level in the mutant TMEM16F-expressing cells (Fig. 2d). When 
cells expressing the wild-type TMEM16F were treated with A23187, PS was exposed 
without a lag time, and reached the saturation level more quickly than the vector-
transformed Ba/F3 (Fig. 2e). The intracellular Ca2+ concentration and the kinetics of the 
Ca2+-influx upon the A23187-treatment was similar among the vector-, wild-type-, and 
D409G mutant TMEM16F-expressing cells (Supplementary Fig. 2). These results 
indicated that TMEM16F mediates a Ca2+-dependent scramblase activity for PS, and 
that its D409G mutant is sensitized to respond to the normal intracellular concentration 
of Ca2+ to expose PS.  
Phospholipid scramblase mediates bidirectional transfer between plasma 
membrane leaflets of all phospholipids. The cells expressing the D409G mutant 
TMEM16F were stained with Ro09-0198 (Supplementary Fig. 3a), a tetracyclic 
polypeptide that specifically binds phosphatidylethanolamine (PE)17, indicating that 
they constitutively exposed PE, a phospholipid that like PS is normally sequestered to 
the inner leaflet. The treatment of Ba/F3 with A23187 caused the PE-exposure. This 
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process was accelerated by over-expressing the wild-type TMEM16F (Supplementary 
Fig. 3b). When NBD-phosphatidylcholine (NBD-PC) was added to the culture, it was 
quickly internalized by the D409G-mutant-expressing cells (Fig. 2f). That is, among the 
cell-associated NBD-PC, more than 40% NBD-PC became resistant to the BSA-
extraction within 6 min. When the cells expressing the wild-type TMEM16F were 
treated with A23187, they incorporated NBD-PC faster than the parental cells, and 
about 40% of the cell-associated NBD-PC was inside of the cells within 4 min (Fig. 2g  
Similar results, i.e., constitutive internalization by cells expressing the mutant 
TMEM16F, and the enhanced A23817-induced incorporation by cells expressing the 
wild-type TMEM16F, were obtained with NBD-sphingomyelin (NBD-
SM)(Supplementary Fig. 4). The internalized NBD-PC and NBD-SM were intact 
(Supplementary Fig. 5). Dynasore that inhibits dynamin-mediated endocytosis18 did 
slightly or not inhibited the internalization of these phospholipids (Supplementary Fig. 
6), suggesting that the contribution of endocytosis in the TMEM16F-mediated 
phospholipid-internalization may not be great.  
The expression of the endogenous TMEM16F in Ba/F3 was then knocked down 
by expressing TMEM16F shRNA. As shown in Fig. 3a and Supplementary Fig. 7, the 
expression level of TMEM16F mRNA in 5 transformants was reduced to 20-35% of 
that in the cells expressing the control shRNA. The rate of A23187-induced exposure of 
PS and PE was reduced in these transformants (Fig. 3b and 3c). Similarly, the uptake of 
NBD-PC and NBD-SM was slower in the TMEM16F shRNA-transformed cells (Fig. 
3d and 3e).  
Platelets and other blood cells from patients with Scott syndrome show a defect in 
their ability to expose PS in response to a Ca2+-ionophore7,19. Kojima et al.20 established 
B-cell lines from a Scott syndrome patient and the patient’s parents. In agreement with 
previous reports8,20, the patient-derived cells did not expose PS in response to a Ca2+-
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ionophore (Fig. 4a). In contrast, A23187 elicited PS exposure in cell lines derived from 
the patient’s parents at the same levels as cell lines from healthy volunteers. An RT-
PCR analysis of the TMEM16F mRNA (GenBank NM_001025356) showed that the 5’ 
part (1320 bp) corresponding to exons 1-12 was identical among the patient and the 
parents, while its 3’ half corresponding to exons 11-20 was shorter in the patient than 
that in the parents (Fig. 4b). A sequence analysis indicated that the cDNA of the patient 
lacked the 226-bp sequence corresponding to exon 13. Direct sequencing of the 
chromosomal DNA indicated that the TMEM16F gene of the patient carried a G-to-T 
homozygous mutation at the splice-acceptor site in intron 12, while both parents were 
heterozygous for the mutation at this position (Fig. 4c). PCR analysis of the TMEM16F 
mRNA with primers at exons 12 and 16 showed a 608-bp band from the control and a 
382-bp band from the Scott-syndrome patient’s cell line (Fig. 4d), indicating that a 
mutation in the splice acceptor site caused exon 13 to be skipped. This skipping caused 
a frame shift, which resulted in the premature termination of the protein in exon 14 (Fig. 
4e) at the third transmembrane segment of human TMEM16F (Fig. 4f). The nonsense-
mediated mRNA decay21 may explain the reduced concentration of the exon 13-deleted 
form of TMEM16F mRNA in the patient’s parents (Fig. 4d).  
Repeated FACS sorting has been used previously to establish cell lines that over-
express a particular cell-surface protein22,23. Here, this method yielded TMEM16F 
carrying a point mutation that rendered the process extremely sensitive to Ca2+, such 
that in the cells expressing the mutated TMEM16F, the phopholipid scramblase 
functioned even in resting cells, in which the cytosolic Ca2+ concentration is below 100 
nM24. The TMEM16 family, to which TMEM16F belongs, consists of 10 members in 
human and mouse5. The founding member of the family, human TMEM16A, is a Ca2+-
dependent Cl--channel11-13. Although the direct binding of Ca2+ to TMEM16 members 
has yet to be demonstrated, the N-terminal region of TMEM16A appears to have a 
regulatory role25. Similarly, the increased Ca2+-sensitivity of the D409G mutant 
7 
suggests that either Ca2+ or a Ca2+-sensing molecule binds to this N-terminal region of 
TMEM16F. The over-expression of TMEM16A in Ba/F3 cells had no effect on the 
ionophore-induced PS exposure (data not shown), suggesting that different members of 
this family have distinct functions. The PS exposure or scrambling of phospholipids 
occurs in other biological processes1,4,26-29, such as the apoptotic cell death, the fusion of 
muscle, bone or trophoblast cells, and the release of neurotransmitters and 
microvesicles. It will be interesting to study whether TMEM16F and/or its related 
members in the TMEM16 family are involved in these processes.   
Methods Summary 
To reversibly expose PS on the cell surface, Ba/F3 cells were treated at 37°C with 
A23187 in Ca2+-free condition. The exposed PS was detected by binding of Annexin V 
at 4°C in the Ca2+-containing Annexin V-binding buffer. A subline (Ba/F3-PS19) of 
Ba/F3 cells that was extremely sensitive to Ca2+-ionophore-elicited PS exposure was 
selected by repeating FACS sorting 19 times with FACSAria (BD Bioscience). A 
cDNA library was established with mRNA from Ba/F3-PS19 in retrovirus vector, and 
the cDNA (TMEM16F) that renders Ba/F3 to constitutively expose PS was identified 
by expression cloning. The EBV-transformed cell lines from a Scott patient and the 
parents were described previously20. The TMEM16F mRNA in these cell lines was 
analyzed by RT-PCR. The TMEM16F chromosomal gene was amplified by PCR from 
the genomic DNA of the cell lines, and directly sequenced by cycle sequencing using an 
ABI 3100 genetic analyzer (Applied Biosystems). The exposure of PS and PE on the 
cell surface was analyzed by binding of Cy5-labelled Annexin V and biotin-labelled 
Ro09-019817, respectively. The internalization of NBD-PC and NBD-SM was analyzed 
by the BSA-extraction method essentially as described30. For knock-down experiment, 
shRNA-retrovirus vectors for TMEM16F and control scrambled sequence were 
obtained from OriGene, and the resultant retrovirus was used to infect Ba/F3 cells.  
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Full Methods and any associated references are available in the online version of 
this paper at www.nature.com/nature. 
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Figure 1. Molecular cloning of TMEM16F. a, Ba/F3, treated with A23187 + 
CaCl2, stained with Annexin V and PI. b, Ba/F3, incubated with BAPTA-AM, 
treated with A23187. Annexin V-profile in PI-negative population. Open, resting 
cells. c, Ba/F3, treated with A23187, then with BAPTA-AM for 5 min, stained 
with Annexin V. d, Ba/F3 and cells after 12 cycles-sorting (PS12), treated with 
A23187, stained with Annexin V. e. GFP and DsRed-profiles of PS0, PS19, and 
PS0/19 hybrid. Bottom, these cells, treated with A23187, stained with Annexin 
V. f, Ba/F3 transformed with PS19 cDNA library, treated with A23187, stained 
with Annexin V, and sorted (LD-PS0). Annexin V- and PI-profile after first (LD-
PS1), and third (LD-PS3) sorting. Right, Annexin V-profile of original (LD-PS0) 
and after fourth sorting (LD-PS4) without A23187.  
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Figure 2. Phospholipids-scrambling in TMEM16F-expressing cells. a, 
Schematic representation of mouse TMEM16F and D409G mutant. b, Western 
blotting of Ba/F3 expressing Flag-wild-type and mutant TMEM16F with anti-
Flag. Arrowheads, monomer and multimer of TMEM16F. c, 293T expressing 
TMEM16F-mRFP, observed by fluorescent microscope. Scale bar, 10 µm. d, 
Ba/F3, transformed with vector, or wild-type or mutant TMEM16F, stained with 
Annexin V + BAPTA-AM pre-treatment. e, Vector- or wild-type TMEM16F-
Ba/F3, preincubated with Annexin V, mixed with A23187, and fluorescence 
monitored. y-axis, fluorescence intensity on FACS in arbitrary units. f, Vector- or 
mutant TMEM16F-expressing Ba/F3, incubated at room temperature with 0.5 
µM NBD-PC in HBSS-Ca2+. After dilution with fatty-acid-free BSA buffer, the 
fluorescence intensity determined by FACS, and shown in arbitrary units. g, 
Vector- or wild-type TMEM16F-expressing Ba/F3, preincubated at 4°C with 0.1 
µM NBD-PC. A23187 added, incubated at room temperature, internalized NBD-
PC determined as above. In f and g, percentage of BSA-non extractable NBD-
PC determined in triplicates, plotted with S.D. All experiments carried out at 
least three times. 
Figure 3. Requirement of TMEM16F for phospholipids-scrambling. a. 
Ba/F3 transformants expressing shRNA for TMEM16F (sh16F) or scrambled 
shRNA (shCon). TMEM16F mRNA level, normalized to β-actin mRNA, and 
shown as relative expression. b and c, sh16F- or shCon-expressing Ba/F3, 
preincubated with Cy5-Annexin V (b) or biotin-Ro09-0198 and APC-streptavidin 
(c). A23187 added, and fluorescence monitored. d and e, sh16F- or shCon-
expressing Ba/F3, preincubated with 0.5 µM NBD-PC (d) or NBD-SM (e) in 
HBSS-Ca2+. A23187 added, incubated, diluted with fatty-acid-free BSA buffer, 
and fluorescence determined. Experiments in b-e carried out at least three 
times. 
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Figure 4. A splice mutation of TMEM16F gene in a Scott patient. a, Cells 
from control, Scott patient, and patient’s parents, preincubated with Annexin V. 
A23187 added, and fluorescence monitored. b, RT-PCR for TMEM16F mRNA 
for exons 1-12 and 11-20 with RNA from the patient and parents. c, The 
junction between exon 13 and intron 12 of TMEM16F gene sequenced from 3’. 
The “CT” complementary to splice acceptor site “AG” underlined. Arrowheads, 
the mutation. d, RT-PCR for exons 12-16. Arrowheads, fragments for wild-type 
and exon 13-deleted form. e and f, Splicing in the patient’s TMEM16F gene. 
The mutation causes skipping of exon 13, resulting in a frame-shift mutation 
with premature termination in 3rd transmembrane region.  
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Methods 
Cell lines, recombinant proteins, antibodies, serum, and reagents. Mouse 
interleukin (IL-3)-dependent Ba/F3 cells were maintained in RPMI containing 10% 
fetal calf serum (FCS, Gibco), 45 units/ml of recombinant mouse IL-3, and 50 µM β-
mercaptoethanol. The EBV-transformed human cell lines20 from a Scott syndrome 
patient and her parents were grown in RPMI1640 containing 10% FCS, and 50 µM β-
mercaptoethanol. Human 293T cells and Plat-E packaging cells31 were cultured in 
DMEM containing 10% FCS. Recombinant mouse IL-3 was produced by mouse C127I 
cells transformed with a bovine papillomavirus expression vector bearing mouse IL-3 
cDNA as described32. Biotin-labeled Ro09-0198 was prepared as described 
previously33. Flag-tagged mouse MFG-E8 was produced in human 293T cells as 
described34, and the secreted MFG-E8 was purified using anti-Flag M2 beads (Sigma-
Aldrich).  
Ca2+/Mg2+-free RPMI1640 medium was purchased from Cell Science & Technology 
Institute. Ca2+-free RPMI medium contained 0.5 mM MgSO4. Ca2+-free FCS was 
prepared by dialyzing FCS for 2 days against PBS with four changes of buffer. 
Dynasore was purchased from Calbiochem. 
BAPTA-AM (O,O'-Bis(2-aminophenyl)ethyleneglycol- N,N,N',N'-tetraacetic acid, 
tetraacetoxymethyl ester) was from Dojindo. 1-oleoyl-2-{6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine (NBD-PC), and N-
{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sphoingosine-1-phosphocoline 
(NBD-SM) were purchased from Avanti Polar Lipids. 
Treatment with Ca2+-ionophore, flow cytometry, and cell sorting. To expose 
phosphatidylserine (PS) on the cell surface, cells (2 x 105 cells) in a 96-well microtiter 
plate were washed with PBS, re-suspended in 200 µl of Hank’s Balanced Salt Solution 
(HBSS, Gibco) and treated with A23187 (Sigma Aldrich) at 37°C for 15 min. The cells 
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were stained on ice for 15 min with 2500-5000-fold diluted Cy5-labeled Annexin V 
(Biovision) in staining buffer (10 mM Hepes-NaOH buffer [pH7.4] containing 140 mM 
NaCl and 2.5 mM CaCl2) in the presence of 5 µg/ml propidium iodide (PI). Flow 
cytometry was performed on a FACSAria (BD Bioscience) or FACSCalibur (BD 
Bioscience), and the data were analyzed using FlowJo Software (True Star).  
A subline of Ba/F3 cells that was sensitive to Ca2+-ionophore-elicited PS exposure 
was selected by repetitive FACS sorting. In brief, after 2 x 107 Ba/F3 cells in HBSS 
were treated at 37°C for 15 min with A23187, they were suspended in 1 ml of Annexin 
V- staining buffer that had been pre-chilled at 4°C. The cells were stained with Cy5-
Annexin V on ice as described above, and sorted using a FACSAria whose injection 
chamber was kept at 4°C. Cells providing the highest level of Cy5-fluorescence signal 
(top 0.5-5.0%) were collected, and re-suspended at a density of more than 1.0 x 105 
cells per ml in Ca2+-free RPMI containing 5% dialyzed FCS, 45 units/ml IL-3, and 50 
µM β-mercaptoethanol. Twenty-four hours later, the cells were re-suspended in normal 
Ca2+-containing RPMI medium, and expanded for the next sorting. 
Construction of the cDNA library. Total RNA was prepared from Ba/F3 PS19 cells 
using an RNeasy Mini Kit (Qiagen), and poly(A) RNA was purified using an mRNA 
Purification Kit (GE Healthcare) with two cycles of oligo(dT)-cellulose column 
chromatography. Double-stranded cDNA was synthesized with random hexamers as 
primers, using a cDNA synthesis kit (SuperScriptTM Choice System for cDNA 
Synthesis, Invitrogen). A Bst XI adaptor was attached, and the fragments were size-
fractionated by electrophoresis through a 1% agarose gel (Seakem® GTG agarose, 
Lonza). DNA fragments longer than 2.5 kb were recovered from the gel using a DNA 
extraction kit (Wizard® SV Gel and PCR Clean-up System, Promega), and ligated into a 
Bst XI-digested pMXs vector35. E. coli DH10B cells (ElectroMax DH10B; Invitrogen) 
were transformed by electroporation using a Gene Pulser (Bio-Rad). About 9.3 x 105 
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clones were produced, and plasmid DNA was prepared using a QIAfilter Plasmid Maxi 
Kit (Qiagen).  
Cell fusion. Ba/F3-PS0 and Ba/F3-PS19 cells were transduced with pMXs-puro EGFP 
and pMXs-neo DsRed, respectively, and cultured in the presence of 1 µg/ml puromycin 
or 1 mg/ml G418. Ba/F3-PS0 EGFP cells and Ba/F3-PS19 DsRed cells were fused in 
the presence of PEG1500, and cultured in the presence of 1 µg/ml puromycin and 1 
mg/ml G418. The EGFP/DsRed double-positive cells were sorted using a FACSAria. 
Screening of cDNA library. Plasmid DNA (108 µg) from the cDNA library was 
introduced by lipofection using FuGENE6 (Roche Diagnostics) into 7.2 x 107 PLAT-E 
packaging cells31 grown in eighteen 10-cm dishes. Two days after the transfection, the 
viruses in the culture supernatant were spun down at 4°C by centrifugation at 6,000 x g 
for 16 h, re-suspended in RPMI1640 medium containing 10% FCS and 45 units/ml IL-
3, and used to infect 7.2 x 106 Ba/F3 cells in the presence of 8 µg/ml polybrene (Sigma-
Aldrich). After a 24-h culture, the medium was replaced with fresh medium, and the 
cells were further cultured for 2 days. The sorting of cells that were sensitive to 
ionophore-induced PS exposure was performed as described above.   
Isolation of cDNA fragments from Annexin V-positive Ba/F3 cells. To isolate the 
cDNA integrated into the retroviral vector, the genomic DNA was extracted from Ba/F3 
cell transformants using the Wizard® Genomic DNA Purification System (Promega), 
and subjected to PCR using the Expand Long Template PCR System (Roche 
Diagnostics). The PCR primers (5’-CCCGGGGGTGGACCATCCTCT-3’ and 5’-
CCCCTTTTTCTGGAGACTAAAT-3’) carried sequences from the pMXs vector, and 
the conditions for PCR were 10 sec at 96ºC, 30 sec at 58ºC, and 4 min at 68ºC for 35 
cycles. The PCR fragments were cloned into the pGEM-T Easy vector (Promega), and 
subjected to DNA sequencing analysis using an ABI PRISM 3100 Genetic Analyzer 
(Applied Biosystems).     
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Expression vector for TMEM16F and its mutants. The Flag-tag sequence was 
integrated into the Eco RI and Xho I sites of the retroviral vector pMXs-puro, resulting 
in pMXs-puro c-Flag. The full-length coding sequences for mouse (m)TMEM16F 
(GenBank NM_175344) was prepared by RT-PCR with the mRNA from Ba/F3 cells. 
The primers used were as follows. (in each primer, the Eco RI recognition sequence is 
underlined):  
mTMEM16F, 5’-ATATGAATTCGACATGCAGATGATGACTAGGAA-3’ and 5’-
ATATGAATTCGACATGCAGATGATGACTAGGAA-3’; 
The PCR fragments were inserted into the Eco RI site of pMXs-puro c-Flag, and the 
authenticity of the cDNAs was verified by DNA sequencing.  
For the expression plasmid of TMEM16F-mRFP, the coding sequence for mRFP in 
pcDNA-mRFP (Invitrogen) was joined in frame to the C-terminus of mouse 
TMEM16F, and introduced into pMXs vector.   
Expression in mouse Ba/F3 and human 293T cells. The expression vector for Flag-
tagged TMEM16F in pMXs-puro was introduced into PlatE cells. The produced 
retrovirus was concentrated as described above, and used to infect Ba/F3 to establish 
stable transformants. The transformants were selected by culturing the cells in medium 
containing puromycin (1.0 µg/ml). To express TMEM16F-mRFP, human 293T cells 
were transfected by the lipofection using FuGENE6 with the pMXs vector carrying the 
TMEM16F-mRFP sequence. One day later, the transfected cells were observed by 
fluorescence microscopy (BioRevo BZ-9000, Keyence).  
Western blotting. Cells were lysed in RIPA buffer (50 mM Hepes-NaOH buffer [pH 
8.0] containing 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 150 mM NaCl, and 
10% protease inhibitor cocktail [Complete Mini, Roche Diagnostics]). The lysate was 
mixed with 5 x SDS sample buffer [200 mM Tris-HCl (pH 6.8), 10% SDS, 25% 
18 
glycerol, 0.5% β-mercaptoethanol, and 0.05% bromophenolblue], boiled for 5 min, and 
separated by electrophoresis on a 10% polyacrylamide gel (Bio Craft). After the 
proteins were transferred to a PVDF membrane (Millipore), the membranes were 
probed with HRP-conjugated mouse anti-FLAG M2 (Sigma), and the peroxidase 
activity was detected by a Western Lightning®-ECL system (PerkinElmer). 
RT-PCR of TMEM16F cDNA and sequencing of its chromosomal gene in Scott 
syndrome patient. Total RNA was prepared from EBV-transformed cell lines from a 
Scott patient and her parents, and from a healthy control. The RNA was reverse-
transcribed using Superscript III (Invitrogen), according to the manufacture’s protocol, 
and the TMEM16F cDNA was analyzed by PCR using the following sets of primers (in 
each primer, the sequence containing the additional restriction site is underlined). Ex1-
FW (5’-ATATGAATTCGACATGAAAAAGATGAGCAGGAA-3’) and Ex11/12-RV 
(5’-GCGTTCTTCTTCCTGAGTAA-3’);  
Ex11/12-FW (5’-TTACTCAGGAAGAAGAACGC -3’) and  
Ex20-RV (5’-ATATGAATTCTTCTGATTTTGGCCGTAAAAT-3’);  
Ex12-FW (5’- TCTGTGCCAGTGCTGTCTTT-3’) and 
Ex16-RV (5’- CTGCAGATGGTAGTCCTGTT-3’). 
For the sequence analysis of the human TMEM16F chromosomal gene, genomic 
DNA was prepared from human cell lines, and a 964-bp DNA fragment carrying the 
226-bp exon 13 and its 5’- and 3’-flanking regions (about 370-bp each) was amplified 
by PCR using the following primers: 5’-CCAGAGTATGCTACTAGTTG-3’ and 5’-
TCTCAGCAACCGAGGAACAT-3’. The PCR products were purified with a Wizard® 
SV PCR and Gel Clean-up System. Cycle sequencing was performed using a BigDye 
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Terminator v3.1 Cycle Sequencing kit with a primer of 5’-
ACATATGTGGATGCGCCTTC-3’, and analyzed by an ABI PRIZM 3100 Genetic 
Analyzer.  
Analysis of exposure of PS and PE. To analyze the exposure of PS and PE, cells (1. 0 
x 105) at the early exponential phase were washed with PBS, suspended in 1.0 ml of 
cold Annexin V-staining buffer with 2500-5000-fold diluted Cy5-labeled Annexin V or 
800-diluted biotin-Ro09-019833 followed by 1.0 µg/ml APC-labeled streptavidin, and 5 
µg/ml PI. The samples were incubated on ice for 15 min, and flow cytometry was 
performed on a FACSAria or FACSCalibur as described above. For binding of MFG-
E8, the cells were suspended in RPMI1640 containing 10% FCS, and incubated on ice 
for 20 min with 0.4 µg/ml of the Flag-tagged D89E mutant of MFG-E834. The cells 
were washed with the above medium, and incubated on ice for 20 min with 1.0 µg/ml 
hamster mAb against mouse MFG-E8 (clone 2422), followed by incubation with PE-
labeled mouse anti-hamster IgG (BD Bioscience), and analyzed by flow cytometry with 
a FACSAria. 
To study the requirement of intracellular Ca2+, cells (1.0 x 105) were incubated with 
10 µM BAPTA-AM in RPMI1640 medium containing 10% FCS at 37°C for 5 min for 
the PS-exposure or for 60 min for the PE-exposure. The cells were washed with 
Annexin V-staining buffer, and stained with Cy5-Annexin V or biotin-Ro09-0198 as 
described above.   
For the kinetic study of the Ca2+-induced PS and PE exposure, cells (1.0 x 106) were 
washed with PBS, suspended in 1.0 ml of cold Annexin V-staining buffer with Cy5-
labeled Annexin V or a mixture of biotin-Ro09-0198 and APC-labeled streptavidin, and 
5 µg/ml PI. Cells were mixed on ice with A23187 at a final concentration of 0.25 or 0.5 
µM, and applied to the injection chamber of a FACSAria that was set at 20°C (for 
Ba/F3 cells) or 37°C (for human cell lines) to induce the A23187 reaction. Data were 
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recorded for the indicated periods and the PI-positive cells were excluded from the 
analysis.  
Internalization of NBD-PC, and -SM. The internalization of NBD-lipid analogies was 
analyzed by flow cytometry essentially as described by Williamson et al.8 In brief, cells 
(106 cells) were washed with HBSS, and resuspended in 0.5 ml of HBSS containing 2 
mM CaCl2 (HBSS-Ca). An equal volume of HBSS-Ca and 1 µM NBD-PC, or NBD-SM 
was added to the cell suspension, and incubated at room temperature. At each time 
point, 150 µl of cell suspension was collected, mixed with 150 µl of the prechilled (4°C) 
HBSS containing 5 mg/ml fatty-acid free BSA (Sigma-Aldrich) to extract the 
unincorporated fluorescent lipids and 500 nM Sytoxblue (Molecular Probes). To 
measure the total fluorescence, samples were mixed with HBSS in the absence of BSA. 
After incubation for 10 min at 4°C to extract the lipid, the cells were analyzed by a 
FACSAria for forward scatter, side scatter, log green fluorescence (NBD), and 
Sytoxblue fluorescence. The Sytoxblue-positive dead cells were excluded from the 
analysis. The data were analyzed with FlowJo Software (Tree Star). The fluorescence of 
NBD-phospholipids that was resistant to the BSA-extraction was regarded to be 
incorporated into cells.    
To examine the effect of the Ca2+ ionophore, cells (5 x 105 cells) were washed with 
HBSS, resuspended in 0.5 ml of cold HBSS-Ca, and incubated on ice for 7 min. Cold 
HBSS (0.5 ml) containing 0.2 µM NBD-PC, or NBD-SM was added to the cell 
suspension and incubated further on ice for 3 min. The cells were then mixed with 
A23187, and incubated at room temperature to induce lipid incorporation. A 150-µl 
aliquot was used to determine the incorporated lipid quantity as described above. 
Thin-layer chromatography. After incubation of cells with NBD-PC or NBD-SM, the 
phospholipids were extracted from the cells with a mixture of chloroform and methanol 
(2:1, v/v). The phospholipids were separated by thin-layer chromatography on a silica 
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gel 60 plate (Merck) using chloroform/acetone/methanol/acetic acid/water (5:2:1:1:0.5 
in volume) as a solvent. The fluorescence on the plate was detected by a LAS4000 
image analyzer (Fuji Film). 
Intracellular Ca2+ and Ca2+ influx. To determine the intracellular Ca2+ concentration, 
cells (1.0 x 106 cells) were suspended in HBSS, incubated at 37°C for 10 min with 0.4 
µM Fluo-4-AM (Molecular Probes), washed with HBSS, and analyzed by FACSAria.  
The Ca2+ influx was measured as described36. In brief, cells (1.0 x 106) were labeled 
with Fluo-4-AM (1 µM) in RPMI containing 10% FCS for 30 min at 37°C. After 
washing with the Annexin V staining buffer, the cells were kept at 4°C in Annexin V-
staining buffer. The Ca2+ ionophore A23187 was added to the mixture at a final 
concentration of 0.5 µM, and the change in mean fluorescence intensity (MFI) was 
directly recorded using FACSCalibur system. The data was analyzed with FlowJo 
Software.     
shRNA. shRNA expression plasmids for mouse TMEM16F in a pRS shRNA vector 
carrying the puromycin-resistance gene were purchased from OriGene. The target 
sequence of the shRNA for TMEM16F was 5’-
CATCTACTCTGTGAAGTTCTTCATTTCCT-3’. The scrambled non-effective 
shRNA (5’- GCACTACCAGAGCTAACTCAGATAGTACT -3’) in pRS was from 
OriGene. Ba/F3 cells were infected with retrovirus containing the shRNA, and cultured 
in the presence of 1.0 µg/ml puromycin. The puromycin-resistant cells were subjected 
to cloning by limited dilution. The TMEM16F mRNA was quantified by real-time PCR, 
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Figure 1. Constitutive binding of MFG-E8 to BaF/3 cells expressing the D409G 
mutant TMEM16F. Ba/F3 cells were infected with the empty, wild-type 
TMEM16F- or D409G mutant TMEM16F-carrying retrovirus vector. The cells 
were incubated with 0.4 µg/ml of mouse MFG-E8, followed by successive 
incubations with hamster anti-mouse MFG-E8 and PE-labelled mouse anti-
hamster IgG as described in Methods. The cells were analyzed by flow 
cytometry using FACSAria, and the staining profile is shown (filled area). The 
staining procedure was also performed without MFG-E8, and its profile is shown 
in open area. 
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Figure 2. No effect of TMEM16F on the Ca2+ influx. a, The vector-, wild-type-, 
or D409G mutant TMEM16F-transformed Ba/F3 cells were loaded with Fluo-4-
AM, and analyzed by FACS. Open area represents the profile without Fluo-4-
AM. b, The vector- or wild-type TMEM16F-transformed Ba/F3 were 
preincubated with Fluo-4-AM. A23187 was added at the point indicated by an 
arrow, and the fluorescence was monitored.  
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Figure 3. Effect of TMEM16F on the exposure of phosphatidylethanolamine. a, 
Ba/F3 cells transformed with vector-, wild-type-, or D409G-mutant TMEM16F 
were incubated with biotin-labeled Ro09-0198 with or without BAPTA-AM pre-
treatment, followed by staining with APC-streptavidin. b, Ba/F3 cells 
transformed with vector or the wild-type TMEM16F were preincubated with 
biotin-Ro09-0198 and APC-streptavidin. A23187 was added, and the 
fluorescence was monitored by flow cytometry. The y-axis is fluorescence 
intensity observed by FACS analysis, and shown in arbitrary units.  
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Figure 4.  Effect of TMEM16F on the internalization of sphingomyelin. a, The 
Ba/F3 cells transformed with the vector or mutant TMEM16F were incubated at 
room temperature with 0.5 µM NBD-SM in HBSS containing Ca2+. At the 
indicated time, samples were diluted with cold, fatty-acid-free BSA-containing 
buffer, and analyzed by flow cytometry. The y-axis is fluorescence intensity 
observed by FACS analysis, and shown in arbitrary units. b, Vector- or wild-type 
TMEM16F-expressing Ba/F3 cells were preincubated at 4°C with 0.1 µM NBD-
SM. A23187 was added, and the NBD-SM internalized at room temperature 
was analyzed as above. In a and b, the percentage of NBD-SM that could not 
be extracted by BSA at the indicated time point was determined in triplicates, 
and plotted with S.D. The experiments were independently performed at least 
three times. 
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Figure 5. No breakdown of NBD-PC and NBD-SM incorporated in the cells. 
NBD-PC (a) or NBD-SM (b) was added to Ba/F3 expressing the D409G mutant 
of TMEM16F, incubated at room temperature for 6 or 8 min, and treated with 
fatty-acid-free BSA. The phospholipids incorporated into the cells were 
extracted from the cells, and analyzed by thin-layer chromatography together 
with the input NBD-PC and NBD-SM. As reference, NBD-derivatives of 
phosphatidic acid (PA), phosphatidylethanolamine (PE), phosphatidylcholine 
(PC), phosphatidylserine (PS), and sphingomyelin (SM) were chromatographed 
in parallel, and their positions on the chromatogram are indicated on right. 
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Figure 6. No inhibition of the phospholipid-internalization by an inhibitor of the 
endocytosis. The Ba/F3 cells transformed with the vector or D409 mutant 
TMEM16F were preincubated at 37°C for 30 min with or without 20 µM 
dynasore in the culture medium. After washing with HBSS, the cells were 
incubated at room temperature with 0.5 µM NBD-PC (a) or NBD-SM (b) in 
HBSS containing Ca2+ in the presence or absence of 20 µM dynasore. At the 
indicated time, samples were diluted with cold, fatty-acid-free BSA-containing 
buffer, and analyzed by flow cytometry. The y-axis is fluorescence intensity 
observed by FACS analysis, and shown in arbitrary units.  
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Figure 7. The effect of knock-down of TMEM16F on the Ca2+-dependent PS 
exposure. The pRS shRNA vector for TMEM16F was introduced into Ba/F3 
cells. Among the Ba/F3 stable transformant clones in which the 
TMEM16F mRNA level is reduced, 5 clones (sh16F #1-5) were picked and 
studied. As a control, a Ba/F3 cell transformant (shCon) established with pRS 
shRNA vector carrying a scrambled non-effective sequence was also analyzed. 
a, The TMEM16F mRNA level in the Ba/F3 transformant clones (sh16F #1-5) 
was determined by real-time PCR, and is shown to relative to that in the control 
Ba/F3 (shCon). b, The Ba/F3 cell transformants (shCon and sh16F #1-5) were 
treated with 1.0 µM A23187 at 37°C for 15 min, stained with Cy5-labelled 
Annexin V, and analyzed by flow cytometry. The transformants were also 
stained with Annexin V without the A23187-treatment, and their staining profile 
is shown in open area.   
 
 
 
